Executive Committee: Recursion Pharmaceuticals, Inc.

Manager
Positions heldSince
Chistopher Gibson

Chistopher Gibson

41 year

Chief Executive Officer 04/11/2013
Founder 04/11/2013
Ganesh Kumar Jagannathan

Ganesh Kumar Jagannathan

Chief Tech/Sci/R&D Officer -
David Mauro

David Mauro

59 year

Chief Tech/Sci/R&D Officer 31/05/2023
Laura Schaevitz

Laura Schaevitz

Chief Tech/Sci/R&D Officer -
Hatfield Nathan

Hatfield Nathan

General Counsel -
Jordan Christensen

Jordan Christensen

Chief Tech/Sci/R&D Officer 15/08/2021
Michael Secora

Michael Secora

41 year

Director of Finance/CFO 29/02/2020
Benjamin Mabey

Benjamin Mabey

41 year

Chief Tech/Sci/R&D Officer 31/12/2019
Tina Larson

Tina Larson

49 year

Chief Operating Officer 30/06/2018
President 30/09/2019
Najat Khan

Najat Khan

Chief Tech/Sci/R&D Officer 15/04/2024

Composition of the Board of Directors: Recursion Pharmaceuticals, Inc.

Director
CommitteesSince
Robert Hershberg

Robert Hershberg

61 year

Compensation Committee Chair
Dean Li

Dean Li

62 year

Compensation Committee 04/11/2013
Governance Committee 04/11/2013
Nominating Committee 04/11/2013
Zavain Dar

Zavain Dar

35 year

Audit Committee 31/08/2016
Governance Committee Chair 31/08/2016
Nominating Committee Chair 31/08/2016
Zachary Bogue

Zachary Bogue

48 year

Compensation Committee 31/07/2018
Audit Committee Chair 11/08/2024
Blake Borgeson

Blake Borgeson

42 year

Governance Committee 04/11/2013
Nominating Committee 04/11/2013
Najat Khan

Najat Khan

Director/Board Member 15/04/2024
Chistopher Gibson

Chistopher Gibson

41 year

Director/Board Member 04/11/2013

Former Officers and Directors: Recursion Pharmaceuticals, Inc.

Insider
Positions held
SinceUntil
Terry-Ann Burrell
Terry-Ann Burrell
Director/Board Member 31/03/2020 11/08/2024
Independent Dir/Board Member 31/03/2020 11/08/2024
Ramon Chavez Márquez
Ramon Chavez Márquez
Director/Board Member 31/03/2020 28/02/2021
Chairman 28/02/2021 02/06/2024
Independent Dir/Board Member 31/03/2020 02/06/2024
Shafique Virani
Shafique Virani
Chief Tech/Sci/R&D Officer 06/06/2022 31/05/2023
Corporate Officer/Principal 31/05/2023 05/02/2024
Irit Rappley
Irit Rappley
Corporate Officer/Principal 31/10/2021 30/11/2023
Heather Kirkby
Heather Kirkby
Human Resources Officer 30/04/2019 30/09/2023
Mason Victors
Mason Victors
Chief Tech/Sci/R&D Officer 30/06/2018 31/12/2019
Corporate Officer/Principal 31/12/2019 31/05/2023
Louisa Daniels
Louisa Daniels
General Counsel 31/12/2020 31/12/2022
Glenn Morrison
Glenn Morrison
Corporate Officer/Principal 29/11/2021 31/12/2022
Brown-Tuttle Meredith
Brown-Tuttle Meredith
General Counsel 30/06/2021 31/08/2022
Ramona Doyle
Ramona Doyle
Chief Tech/Sci/R&D Officer 30/11/2020 06/06/2022
Lisa Boyette
Lisa Boyette
Corporate Officer/Principal 31/10/2021 31/05/2022
Adeline Low
Adeline Low
Corporate Officer/Principal 31/05/2019 31/03/2022
Elyse Freeman
Elyse Freeman
Public Communications Contact - 28/02/2022
Ron Alfa
Ron Alfa
Chief Tech/Sci/R&D Officer 11/05/2021 31/01/2022
Sharathchandra Hegde
Sharathchandra Hegde
Chief Tech/Sci/R&D Officer 31/07/2019 11/05/2021
Nickolas Mark
Nickolas Mark
Consultant / Advisor 31/12/2018 31/12/2020
Martin Brenner
Martin Brenner
Chief Tech/Sci/R&D Officer 31/12/2016 31/12/2017
Reid Hutchins
Reid Hutchins
Director/Board Member 31/12/2014 -
Nan Li
Nan Li
Director/Board Member - -
H. Perry Fell
H. Perry Fell
Director/Board Member - -

Age distribution of managers

Parity Men Women

Male 19
Female 3

Of which Executive Committee

Male 8
Female 2

Of which Directors

Male 7
Female 0
ESG Refinitiv
B-

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy
Logo Recursion Pharmaceuticals, Inc.
Recursion Pharmaceuticals, Inc. is a clinical-stage TechBio company decoding biology to industrialize drug discovery. Its Recursion Operating System (OS), a platform built across diverse technologies, enables the Company to map and navigate trillions of biological and chemical relationships within the Recursion Data Universe. The Company integrates physical and digital components as iterative loops of atoms and bits scaling wet lab biology and chemistry data organized into virtuous cycles with computational tools to rapidly translate in silico hypotheses into validated insights and novel chemistry. Its clinical programs include REC-994, REC-2282, REC-4881 and REC-3964. REC-994 is an orally bioavailable, superoxide scavenger small molecule being development for the treatment of symptomatic cerebral cavernous malformation (CCM). REC-2282 for the potential treatment of neurofibromatosis type 2. REC-3964 for the prevention of recurrent Clostridioides difficile infection.
Employees
500
More about the company

Departures of Key Persons

Ramon Chavez Márquez
-
Ramon Chavez Márquez

Chairman

28/02/2021 02/06/2024

-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities. Last hours!
BENEFIT NOW